Back to search

National and Kapodistrian University of Athens

Σύνθεση νέων ετεροκυκλικών αναλόγων με πιθανή αντιπαρασιτική δράση

Abstract

dc:description

According to the World Health Organization (WHO), millions of people die every year from neglected tropical diseases such as Human African Trypanosomiasis (HAT) and Leishmaniasis. The available treatments for these diseases present significant challenges, including severe side effects, the need for prolonged and costly therapy, and the emergence of parasite resistance. iltefosine (Hexadecylphosphocholine) was the first orally administered drug for the treatment of visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL). However, it is associated with serious side effects, a low therapeutic index, and a long half life, which underscores the need for the development of new treatments with greater efficacy and lower toxicity against neglected diseases. To address the adverse effects of miltefosine, the aim of this doctoral dissertation was the design and synthesis of new antiparasitic compounds, expanding the chemical diversity of potential drugs for neglected diseases. Specifically, 40 new alkylphosphocholine analogues were synthesized, in which the phosphate group was bioisosterically replaced by a 4-thiazolidinone ring.The biological evaluation was conducted by the research group of Professor Anabela Cordeiro-da-Silva at the Institute of Molecular and Cell Biology of the Institute for Research and Innovation of the University of Porto (i3S). The biological studies confirmed the antiparasitic activity of the new analogues. Some of these analogues exhibited activity against T. brucei, the etiological agent of HAT, while others were effective against the amastigote form of L. infantum, the parasite responsible for human leishmaniasis. Certain analogues demonstrated efficacy against both parasites. Further studies on one of the new compounds against different Leishmania strains revealed equally satisfactory activity across all strains while miltefosine’s efficacy varies depending on the parasite species. Additionally, the evaluation of two analogues against miltefosine-resistant L. infantum strains yielded highly encouraging results. These findings suggest that the bioisosteric substitution of the phosphate group in alkylphosphocholines with a 4-thiazolidinone group is a promising strategy for the design of new potent and selective drugs for the treatment of parasitic diseases. Additionally, in vitro ADME-Tox studies of selected analogues were performed to assess their interactions with cytochrome P450 enzymes by the group of Dr Theodora Katsila at the Institute of Chemical Biology of the National Hellenic Research Foundation. Specifically, the metabolic stability in human liver microsomes and the metabolism via CYP450 enzymes were investigated for selected 4-thiazolidinone analogues that exhibited strong antileishmanial and/or antitrypanosomal activity with low toxicity. All analogues showed slow or moderate degradation at t = 60 minutes. Furthermore, all analogues were found to be weak or moderate inhibitors of the CYP450 enzyme system, except for one analogue, which proved to be a strong inhibitor of CYP2A6, suggesting that potential drug interaction with CYP2A6 may arise. Finally, the results of the pharmacokinetic analysis using the Snapshot PK method provided information on the absorption, distribution, and clearance of selected compounds. These data led to further investigation of their antileishmanial activity in female BALB/c mice infected with L. infantum amastigotes expressing luciferase administered orally 20mg/Kg/day for 10 days. However, the selected molecules did not exhibit significant antiparasitic activity in the BALB/c model. Given that the compounds tested had a favorable snapshot pharmacokinetic profile and microsomal stability, the absence of antiparasitic activity in vivo may be due to poor targeting to specific organs or unexpected changes in the properties of the molecule. Leishmania infection has a specific tropism to target organs and bioaccumulation in them is important for parasite clearance. Further studies are needed to understand the lack of antileishmanial activity in vivo, but a possible explanation is that the compounds, despite being bioavailable in the blood, are not properly distributed to target organs such as the spleen, liver, and bone marrow. Indeed, formulating the compounds in a suitable pharmaceutical form could allow them to reach the target organs and at the same time enhance their activity in vivo.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chazapi, Evanthia
  • Χαζάπη, Ευανθία

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/58880

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chazapi, Evanthia; Χαζάπη, Ευανθία. Σύνθεση νέων ετεροκυκλικών αναλόγων με πιθανή αντιπαρασιτική δράση. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/58880